The Truth About A1c

Did you know this truth about HbA1c?

Recent Content

Long-term use of this SGLT2 inhibitor revealed sustained clinical benefits in older patients with diabetes and most AEs reported were mild.

 SGLT2-I Use in the Elderly

SGLT2 inhibitors perform well in older patients and cause minimal hypoglycemia. But caution is advised and here are 5 reasons why.

Liraglutide 3 mg (Saxenda) is approved for use in adults with BMI >30 or with BMI >27 and one significant obesity-related condition.

A recent meta-analysis found that patients treated with a combination of a GLP-1 agonist and basal insulin had a significantly greater A1c reduction than patients on any other treatment regimen.

Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.

In the international diabetes community the topic of hemoglobin A1c (HbA1c) continues to generate controversy for a number of reasons. 

Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?

By clicking Accept, you agree to become a member of the UBM Medica Community.